Acotiamide
From Wikipedia, the free encyclopedia
Clinical data | |
---|---|
Routes of administration |
Oral |
ATC code | none |
Legal status | |
Legal status |
|
Identifiers | |
|
|
CAS Number | 185106-16-5 |
PubChem (CID) | 5282338 |
ChemSpider | 4445505 |
UNII | D42OWK5383 |
ChEMBL | CHEMBL2107723 |
Chemical and physical data | |
Formula | C21H30N4O5S |
Molar mass | 450.55 g/mol |
3D model (Jmol) | Interactive image |
|
|
|
|
(what is this?) (verify) |
Acotiamide (YM-443, Z-338) is a drug approved in Japan for the treatment of postprandial fullness, upper abdominal bloating, and early satiation due to functional dyspepsia.[1] It acts as an acetylcholinesterase inhibitor.
References[edit]
- ^ Matsueda K, Hongo M, Tack J, Aoki H, Saito Y, Kato H (January 2010). "Clinical trial: dose-dependent therapeutic efficacy of acotiamide hydrochloride (Z-338) in patients with functional dyspepsia - 100 mg t.i.d. is an optimal dosage". Neurogastroenterology and Motility : the Official Journal of the European Gastrointestinal Motility Society. 22 (6): 618–e173. doi:10.1111/j.1365-2982.2009.01449.x. PMID 20059698.
This article about an amine is a stub. You can help Wikipedia by expanding it. |
This drug article relating to the gastrointestinal system is a stub. You can help Wikipedia by expanding it. |